Report significant palpitations or rates above 100 bpm at rest to your provider
GLP-1 helps regulate blood sugar levels by stimulating the release of insulin, suppressing glucagon secretion (which raises blood sugar levels), and slowing the rate at which the stomach empties, leading to a feeling of fullness and reduced appetite
The clinical protocols align with the Endocrine Society's 2024 Obesity Pharmacotherapy Guideline and the AACE Comprehensive Type 2 Diabetes Management Algorithm 2024, per the brand's published medical review policy
and international insurance coverage policies that consider both the clinical benefits of GLP-1 drugs and the economic realities of varying health care systems
The early deterioration of diabetic retinopathy observed with GLP-1 RAs may reflect rapid glucose decline that affects osmotic pressure rather than direct retinal toxicity [91]
It reports cases of fraudulent compounded drugs, dosing concerns causing hospitalizations, and illegal online sales of drugs